SAB-142 was generally well-tolerated among healthy volunteers; data from Phase 1 trial confirms SAB-142 does not cause serum ...

Study objective Stillbirth is burdensome in low-income and middle-income countries (LMICs), especially in sub-Saharan Africa ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

SAB-142 was generally well-tolerated among healthy volunteers; data from Phase 1 trial confirms SAB-142 does not cause serum sickness or anti-drug antibodies at target dose Study results support that ...

The meeting invited residents to share their flooding experiences over the past few years. The study hopes to offer potential ...

Leap Therapeutics, Inc. (NASDAQ:LPTX) released significant updates regarding its recent clinical findings and corporate presentation. In a press release titled “Leap Therapeutics Reports Initial ...

The world's largest clinical research trial in hyperbaric medicine is taking place on the USF Campus right now, studying its impact on Traumatic Brain Injury.

SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.

Self-driving vehicles are also set to see a number of advancements going forward. Self-driving cars are classified into six ...

Compromised sleep continuity and initiation may underlie the link between depression and difficulty sleeping among older adults.

The objectives of the research presented in this report were to identify case studies of community-led HIV-related health and social inclusion service delivery organizations in eastern and southern ...

Follow-up studies published in 1992, 2004, 2012 and 2022 corroborated trends, though details differed. Some specific ...